Family Heart Foundation Partners With Seven Health Systems to Advance Cardiovascular Screening

Family Heart Foundation Expands FIND Lp(a)™ Initiative With Seven Major Healthcare System Partnerships to Accelerate Screening and Diagnosis of a Silent Cardiovascular Risk The Family Heart Foundation, a nationally recognized research and advocacy organization dedicated to advancing the prevention, early…

Read MoreFamily Heart Foundation Partners With Seven Health Systems to Advance Cardiovascular Screening

QuidelOrtho Appoints Erich Wolff as EVP of Strategy & Corporate Development

QuidelOrtho Appoints Erich Wolff as Executive Vice President of Strategy & Corporate Development, Strengthening Global Diagnostics Growth Ambitions QuidelOrtho Corporation, a leading global innovator in in vitro diagnostics, announced the appointment of Erich Wolff as its new Executive Vice President…

Read MoreQuidelOrtho Appoints Erich Wolff as EVP of Strategy & Corporate Development

Curant Rare Partners as Exclusive Pharmacy for FDA-Approved Neuroblastoma Drug IWILFIN™

Curant Rare Becomes Exclusive Pharmacy Partner for IWILFIN™, Transforming Access and Care for High-Risk Neuroblastoma Patients Curant Health has announced a major milestone in oncology care through its specialty division, Curant Rare, which is now the exclusive pharmacy partner for…

Read MoreCurant Rare Partners as Exclusive Pharmacy for FDA-Approved Neuroblastoma Drug IWILFIN™